Ulcerative Colitis Market Size, Business Revenue Forecast, Leading Competitors

Posted by ojasdbmr on May 4th, 2021

Global ulcerative colitis market is expected to rise gradually to an estimated value of USD 10.51 billion by 2026, registering a CAGR of 5.3% in the forecast period of 2021-2028. Ulcerative colitis is a chronic disease that affects the colon of large intestine. It is characterized by inflammation in the large intestine, and the symptoms include blood in the stool, diarrhea and abdominal pain.

Key Market Competitors: Global Ulcerative colitis Market

Few of the major competitors currently working in the ulcerative colitis market are Allergan, Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, Bayer AG, UCB S.A., Perrigo Company plc, Pfizer Inc., Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Eli Lilly and Co., Sanofi Aventis A/S, AstraZeneca, Merck & Co., Inc., InDex Pharmaceuticals Holding AB, AJINOMOTO CO.,INC., Abbott, Circle33, LLC, BioLineRx, CELGENE CORPORATION, Mitsubishi Tanabe Pharma Corporation, Salix Pharmaceuticals, Inc. and few among others.

Download PDF Sample report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-ulcerative-colitis-market

Segmentation: Global Ulcerative colitis Market

  •          By Type (Ulcerative Proctitis, Proctosigmoiditis, Left-Sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis)
  •          By Drug Type (Anti-Inflammatory Drugs, Aminosalicylates, Corticosteroids, Anti-TNF biologics, Immunosuppressant, Calcineurin Inhibitors, Other)
  •          By Molecule type (Small Molecules, Biologics)
  •          By Route of Administration (Parentral, Oral)
  •          By End- User (Hospital Pharmacies, Retail Pharmacies, Drug Store, E-commerce)

Competitive Analysis: Global Ulcerative colitis Market

Global ulcerative colitis market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of ulcerative colitis market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Drivers

  •          Rise in the incidence and prevalence rate of the disease will drive the growth of the market
  •          Large number of pipeline molecule will help the market to grow
  •          Rise in the government and non-government investment in the R&D

Market Restraints

  •          Strict government regulations Is restraining the market growth
  •          Patent expiry of blockbuster drugs will result in generic and biosimilar competition
  •          Lower incidence rate in Asia- pacific regions restricts the growth of market in that particular area

Reasons to Purchase this Report

  •          Current and future of global ulcerative colitis market outlook in the developed and emerging markets
  •          The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  •          Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  •          The latest developments, market shares, and strategies that are employed by the major market players


Like it? Share it!


About the Author

Joined: October 1st, 2019
Articles Posted: 202

More by this author